This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (181)  • Contact me when this article is cited  Related Content  • Related letter  • Related articles  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Macular Degeneration  • Randomized Controlled Trial  • Articles for Residents  • Alert me on articles by topic

AREDS Report No. 8

Age-Related Eye Disease Study Research Group

Arch Ophthalmol. 2001;119:1417-1436.

Background  Observational and experimental data suggest that antioxidant and/or zinc supplements may delay progression of age-related macular degeneration (AMD) and vision loss.

Objective  To evaluate the effect of high-dose vitamins C and E, beta carotene, and zinc supplements on AMD progression and visual acuity.

Design  The Age-Related Eye Disease Study, an 11-center double-masked clinical trial, enrolled participants in an AMD trial if they had extensive small drusen, intermediate drusen, large drusen, noncentral geographic atrophy, or pigment abnormalities in 1 or both eyes, or advanced AMD or vision loss due to AMD in 1 eye. At least 1 eye had best-corrected visual acuity of 20/32 or better. Participants were randomly assigned to receive daily oral tablets containing: (1) antioxidants (vitamin C, 500 mg; vitamin E, 400 IU; and beta carotene, 15 mg); (2) zinc, 80 mg, as zinc oxide and copper, 2 mg, as cupric oxide; (3) antioxidants plus zinc; or (4) placebo.

Main Outcome Measures  (1) Photographic assessment of progression to or treatment for advanced AMD and (2) at least moderate visual acuity loss from baseline (15 letters). Primary analyses used repeated-measures logistic regression with a significance level of .01, unadjusted for covariates. Serum level measurements, medical histories, and mortality rates were used for safety monitoring.

Results  Average follow-up of the 3640 enrolled study participants, aged 55-80 years, was 6.3 years, with 2.4% lost to follow-up. Comparison with placebo demonstrated a statistically significant odds reduction for the development of advanced AMD with antioxidants plus zinc (odds ratio [OR], 0.72; 99% confidence interval [CI], 0.52-0.98). The ORs for zinc alone and antioxidants alone are 0.75 (99% CI, 0.55-1.03) and 0.80 (99% CI, 0.59-1.09), respectively. Participants with extensive small drusen, nonextensive intermediate size drusen, or pigment abnormalities had only a 1.3% 5-year probability of progression to advanced AMD. Odds reduction estimates increased when these 1063 participants were excluded (antioxidants plus zinc: OR, 0.66; 99% CI, 0.47-0.91; zinc: OR, 0.71; 99% CI, 0.52-0.99; antioxidants: OR, 0.76; 99% CI, 0.55-1.05). Both zinc and antioxidants plus zinc significantly reduced the odds of developing advanced AMD in this higher-risk group. The only statistically significant reduction in rates of at least moderate visual acuity loss occurred in persons assigned to receive antioxidants plus zinc (OR, 0.73; 99% CI, 0.54-0.99). No statistically significant serious adverse effect was associated with any of the formulations.

Conclusions  Persons older than 55 years should have dilated eye examinations to determine their risk of developing advanced AMD. Those with extensive intermediate size drusen, at least 1 large druse, noncentral geographic atrophy in 1 or both eyes, or advanced AMD or vision loss due to AMD in 1 eye, and without contraindications such as smoking, should consider taking a supplement of antioxidants plus zinc such as that used in this study.

The AREDS investigators have no commercial or proprietary interest in the supplements used in this study.

RELATED LETTER

Participants and Methods in AREDS Report No. 8
W. Rex Hawkins
Arch Ophthalmol. 2008;126(1):146-147.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Antioxidants and Zinc to Prevent Progression of Age-Related Macular Degeneration
Lee M. Jampol and Frederick L. Ferris, III
JAMA. 2001;286(19):2466-2468.
EXTRACT | FULL TEXT  

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9
Age-Related Eye Disease Study Research Group
Arch Ophthalmol. 2001;119(10):1439-1452.
ABSTRACT | FULL TEXT  

Antioxidants, Zinc, and Age-Related Macular Degeneration: Results and Recommendations
Lee M. Jampol
Arch Ophthalmol. 2001;119(10):1533-1534.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The rationale and evidence base for a protective role of macular pigment in age-related maculopathy
Loane et al.
Br. J. Ophthalmol. 2008;92:1163-1168.
ABSTRACT | FULL TEXT  

Update: A 76-Year-Old Man With Macular Degeneration
Farag et al.
JAMA 2008;300:91-92.
FULL TEXT  

Selective Degeneration of Central Photoreceptors after Hyperbaric Oxygen in Normal and Metallothionein-Knockout Mice
Nachman-Clewner et al.
IOVS 2008;49:3207-3215.
ABSTRACT | FULL TEXT  

Lutein and zeaxanthin for macular degeneration
Zhao and Sweet
Am J Health Syst Pharm 2008;65:1232-1238.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration
Jager et al.
NEJM 2008;358:2606-2617.
FULL TEXT  

Demonstration by Redox Fluorometry that Sulforaphane Protects Retinal Pigment Epithelial Cells against Oxidative Stress
Cano et al.
IOVS 2008;49:2606-2612.
ABSTRACT | FULL TEXT  

Racial Differences and Other Risk Factors for Incidence and Progression of Age-Related Macular Degeneration: Salisbury Eye Evaluation (SEE) Project
Chang et al.
IOVS 2008;49:2395-2402.
ABSTRACT | FULL TEXT  

The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation
Johnson et al.
Am. J. Clin. Nutr. 2008;87:1521-1529.
ABSTRACT | FULL TEXT  

Modulation of Nrf2-Dependent Antioxidant Functions in the RPE by Zip2, a Zinc Transporter Protein
Rezaei et al.
IOVS 2008;49:1665-1670.
ABSTRACT | FULL TEXT  

Essential Roles of the PI3 Kinase/Akt Pathway in Regulating Nrf2-Dependent Antioxidant Functions in the RPE
Wang et al.
IOVS 2008;49:1671-1678.
ABSTRACT | FULL TEXT  

The Protective Effect of Quercetin against Oxidative Stress in the Human RPE In Vitro
Kook et al.
IOVS 2008;49:1712-1720.
ABSTRACT | FULL TEXT  

The Role of Selenium in Chronic Disease
Boosalis
Nutr Clin Pract 2008;23:152-160.
ABSTRACT | FULL TEXT  

Expression of ZnT and ZIP Zinc Transporters in the Human RPE and Their Regulation by Neurotrophic Factors
Leung et al.
IOVS 2008;49:1221-1231.
ABSTRACT | FULL TEXT  

Associations Between Age-Related Nuclear Cataract and Lutein and Zeaxanthin in the Diet and Serum in the Carotenoids in the Age-Related Eye Disease Study (CAREDS), an Ancillary Study of the Women's Health Initiative
Moeller et al.
Arch Ophthalmol 2008;126:354-364.
ABSTRACT | FULL TEXT  

Age-related macular degeneration: diagnosis and management
Cook et al.
Br Med Bull 2008;85:127-149.
ABSTRACT | FULL TEXT  

Complement-Associated Deposits in the Human Retina
Seth et al.
IOVS 2008;49:743-750.
ABSTRACT | FULL TEXT  

Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium
Csaky et al.
IOVS 2008;49:479-489.
FULL TEXT  

Racial Differences in the Prevalence of Age-Related Macular Degeneration: The Salisbury Eye Evaluation (SEE) Project
Bressler et al.
Arch Ophthalmol 2008;126:241-245.
ABSTRACT | FULL TEXT  

Participants and Methods in AREDS Report No. 8
Hawkins
Arch Ophthalmol 2008;126:146-147.
FULL TEXT  

Lutein and Zeaxanthin Protect Photoreceptors from Apoptosis Induced by Oxidative Stress: Relation with Docosahexaenoic Acid
Chucair et al.
IOVS 2007;48:5168-5177.
ABSTRACT | FULL TEXT  

Intraocular Pressure in Patients With Uveitis Treated With Fluocinolone Acetonide Implants
Goldstein et al.
Arch Ophthalmol 2007;125:1478-1485.
ABSTRACT | FULL TEXT  

Successful design and conduct of genome-wide association studies
Amos
Hum Mol Genet 2007;16:R220-R225.
ABSTRACT | FULL TEXT  

The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice
Fu et al.
Hum Mol Genet 2007;16:2411-2422.
ABSTRACT | FULL TEXT  

Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis
Chong et al.
BMJ 2007;335:755-755.
ABSTRACT | FULL TEXT  

Primary prevention of age related macular degeneration
Evans
BMJ 2007;335:729-729.
FULL TEXT  

Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study
Chiu et al.
Am. J. Clin. Nutr. 2007;86:1210-1218.
ABSTRACT | FULL TEXT  

SOD2 Knockdown Mouse Model of Early AMD
Justilien et al.
IOVS 2007;48:4407-4420.
ABSTRACT | FULL TEXT  

Age-related macular degeneration: what do patients find on the internet?
Rennie et al.
JRSM 2007;100:473-477.
ABSTRACT | FULL TEXT  

Incident Choroidal Neovascularization in Fellow Eyes of Patients With Unilateral Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: SST Report No. 20 From the Submacular Surgery Trials Research Group
Submacular Surgery Trials Research Group
Arch Ophthalmol 2007;125:1323-1330.
ABSTRACT | FULL TEXT  

Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study
Lotery et al.
Br. J. Ophthalmol. 2007;91:1303-1307.
ABSTRACT | FULL TEXT  

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2007;125:1225-1232.
ABSTRACT | FULL TEXT  

Burden and Health Care Resource Utilization in Neovascular Age-Related Macular Degeneration: Findings of a Multicountry Study
Soubrane et al.
Arch Ophthalmol 2007;125:1249-1254.
ABSTRACT | FULL TEXT  

Macular Degeneration: Risk Factors for Progression
Wiggs
Arch Ophthalmol 2007;125:1264-1265.
FULL TEXT  

Oxidative Stress Modulates Complement Factor H Expression in Retinal Pigmented Epithelial Cells by Acetylation of FOXO3
Wu et al.
J. Biol. Chem. 2007;282:22414-22425.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration and Retinal Protein Modification by 4-Hydroxy-2-nonenal
Ethen et al.
IOVS 2007;48:3469-3479.
ABSTRACT | FULL TEXT  

Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study
Chiu et al.
Am. J. Clin. Nutr. 2007;86:180-188.
ABSTRACT | FULL TEXT  

Genetics of Pigment Changes and Geographic Atrophy
Thompson et al.
IOVS 2007;48:3005-3013.
ABSTRACT | FULL TEXT  

The 100 Most Frequently Cited Articles in Ophthalmology Journals
Ohba et al.
Arch Ophthalmol 2007;125:952-960.
ABSTRACT | FULL TEXT  

Fine-scale linkage disequilibrium mapping of age-related macular degeneration in the complement factor H gene region
Ennis et al.
Br. J. Ophthalmol. 2007;91:966-970.
ABSTRACT | FULL TEXT  

Association Between Vitamin D and Age-Related Macular Degeneration in the Third National Health and Nutrition Examination Survey, 1988 Through 1994
Parekh et al.
Arch Ophthalmol 2007;125:661-669.
ABSTRACT | FULL TEXT  

The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 20
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2007;125:671-679.
ABSTRACT | FULL TEXT  

Zinc: Mechanisms of Host Defense
Prasad
J. Nutr. 2007;137:1345-1349.
ABSTRACT | FULL TEXT  

Age-related macular degeneration and recent developments: new hope for old eyes?
Morris et al.
Postgrad. Med. J. 2007;83:301-307.
ABSTRACT | FULL TEXT  

Association of CFH Y402H and LOC387715 A69S With Progression of Age-Related Macular Degeneration
Seddon et al.
JAMA 2007;297:1793-1800.
ABSTRACT | FULL TEXT  

Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?
Sutter et al.
IOVS 2007;48:1472-1475.
ABSTRACT | FULL TEXT  

Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress
Prasad et al.
Am. J. Clin. Nutr. 2007;85:837-844.
ABSTRACT | FULL TEXT  

The LOC387715 Polymorphism and Age-Related Macular Degeneration: Replication in Three Case-Control Samples
Ross et al.
IOVS 2007;48:1128-1132.
ABSTRACT | FULL TEXT  

Beta Carotene Supplementation and Age-Related Maculopathy in a Randomized Trial of US Physicians
Christen et al.
Arch Ophthalmol 2007;125:333-339.
ABSTRACT | FULL TEXT  

HPLC Measurement of Ocular Carotenoid Levels in Human Donor Eyes in the Lutein Supplementation Era
Bhosale et al.
IOVS 2007;48:543-549.
ABSTRACT | FULL TEXT  

New treatments for age-related macular degeneration
Imrie and Bailey
Age Ageing 2007;36:8-10.
FULL TEXT  

Acceleration of Age-Related Changes in the Retina in {alpha}-Tocopherol Transfer Protein Null Mice Fed a Vitamin E-Deficient Diet
Tanito et al.
IOVS 2007;48:396-404.
ABSTRACT | FULL TEXT  

Neovascular Age-Related Macular Degeneration and Its Association With LOC387715 and Complement Factor H Polymorphism
Shuler et al.
Arch Ophthalmol 2007;125:63-67.
ABSTRACT | FULL TEXT  

Hypoglycemia leads to age-related loss of vision
Umino et al.
Proc. Natl. Acad. Sci. USA 2006;103:19541-19545.
ABSTRACT | FULL TEXT  

Phototransduction, Dark Adaptation, and Rhodopsin Regeneration The Proctor Lecture
Lamb and Pugh
IOVS 2006;47:5138-5152.
FULL TEXT  

Dose-Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older
Rosenthal et al.
IOVS 2006;47:5227-5233.
ABSTRACT | FULL TEXT  

Activation of Caspase-8 and Caspase-12 Pathways by 7-Ketocholesterol in Human Retinal Pigment Epithelial Cells
Luthra et al.
IOVS 2006;47:5569-5575.
ABSTRACT | FULL TEXT  

The Economic Burden of Major Adult Visual Disorders in the United States
Rein et al.
Arch Ophthalmol 2006;124:1754-1760.
ABSTRACT | FULL TEXT  

Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium
Zhou et al.
Proc. Natl. Acad. Sci. USA 2006;103:16182-16187.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration
de Jong
NEJM 2006;355:1474-1485.
FULL TEXT  

Oxidant-mediated Akt Activation in Human RPE Cells.
Yang et al.
IOVS 2006;47:4598-4606.
ABSTRACT | FULL TEXT  

Consumption of One Egg Per Day Increases Serum Lutein and Zeaxanthin Concentrations in Older Adults without Altering Serum Lipid and Lipoprotein Cholesterol Concentrations
Goodrow et al.
J. Nutr. 2006;136:2519-2524.
ABSTRACT | FULL TEXT  

Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration
Ebrahem et al.
Proc. Natl. Acad. Sci. USA 2006;103:13480-13484.
ABSTRACT | FULL TEXT  

The Efficacy and Safety of Multivitamin and Mineral Supplement Use To Prevent Cancer and Chronic Disease in Adults: A Systematic Review for a National Institutes of Health State-of-the-Science Conference
Huang et al.
ANN INTERN MED 2006;145:372-385.
ABSTRACT | FULL TEXT  

Potential value of antioxidant-rich foods in slowing age-related macular degeneration.
Mares
Arch Ophthalmol 2006;124:1339-1340.
FULL TEXT  

Micronutrients in health and disease.
Shenkin
Postgrad. Med. J. 2006;82:559-567.
ABSTRACT | FULL TEXT  

Ageing changes in the eye.
Salvi et al.
Postgrad. Med. J. 2006;82:581-587.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration and Risk for Stroke
Wong et al.
ANN INTERN MED 2006;145:98-106.
ABSTRACT | FULL TEXT  

Retinal localization and copper-dependent relocalization of the Wilson and menkes disease proteins.
Krajacic et al.
IOVS 2006;47:3129-3134.
ABSTRACT | FULL TEXT  

Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death.
Hanneken et al.
IOVS 2006;47:3164-3177.
ABSTRACT | FULL TEXT  

The {beta}-Adrenergic Receptor Antagonist Metipranolol Blunts Zinc-Induced Photoreceptor and RPE Apoptosis.
Osborne and Wood
IOVS 2006;47:3178-3186.
ABSTRACT | FULL TEXT  

Cigarette Smoking, Fish Consumption, Omega-3 Fatty Acid Intake, and Associations With Age-Related Macular Degeneration: The US Twin Study of Age-Related Macular Degeneration
Seddon et al.
Arch Ophthalmol 2006;124:995-1001.
ABSTRACT | FULL TEXT  

Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition
Tuo et al.
Proc. Natl. Acad. Sci. USA 2006;103:9256-9261.
ABSTRACT | FULL TEXT  

Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Zambarakji et al.
IOVS 2006;47:2623-2631.
ABSTRACT | FULL TEXT  

Increased Glutathione Synthesis through an ARE-Nrf2-Dependent Pathway by Zinc in the RPE: Implication for Protection against Oxidative Stress.
Ha et al.
IOVS 2006;47:2709-2715.
ABSTRACT | FULL TEXT  

Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration
Johnson and Schaefer
Am. J. Clin. Nutr. 2006;83:S1494-1498S.
ABSTRACT | FULL TEXT  

A 76-year-old man with macular degeneration.
Arroyo
JAMA 2006;295:2394-2406.
FULL TEXT  

High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture
Ishida et al.
Br. J. Ophthalmol. 2006;90:616-620.
ABSTRACT | FULL TEXT  

Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration.
Chiu et al.
Am. J. Clin. Nutr. 2006;83:880-886.
ABSTRACT | FULL TEXT  

Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).
Augood et al.
Arch Ophthalmol 2006;124:529-535.
ABSTRACT | FULL TEXT  

Choroidal neovascularisation and atrophy.
Sunness
Br. J. Ophthalmol. 2006;90:398-399.
FULL TEXT  

Nutritional supplements for macular degeneration
DTB 2006;44:9-11.
ABSTRACT | FULL TEXT  

Dietary Intake of Antioxidants and Risk of Age-Related Macular Degeneration
van Leeuwen et al.
JAMA 2005;294:3101-3107.
ABSTRACT | FULL TEXT  

Strong Labeling for Iron and the Iron-Handling Proteins Ferritin and Ferroportin in the Photoreceptor Layer in Age-Related Macular Degeneration
Dentchev et al.
Arch Ophthalmol 2005;123:1745-1746.
FULL TEXT  

Role of Diet in Prostate Cancer Development and Progression
Chan et al.
JCO 2005;23:8152-8160.
ABSTRACT | FULL TEXT  

(R)-{alpha}-Lipoic Acid Protects Retinal Pigment Epithelial Cells from Oxidative Damage
Voloboueva et al.
IOVS 2005;46:4302-4310.
ABSTRACT | FULL TEXT  

The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 17
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1484-1498.
ABSTRACT | FULL TEXT  

A Simplified Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 18
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1570-1574.
ABSTRACT | FULL TEXT  

Prevalence of Age-Related Macular Degeneration in a Population-Based Sample of Hispanic People in Arizona: Proyecto VER
Munoz et al.
Arch Ophthalmol 2005;123:1575-1580.
ABSTRACT | FULL TEXT  

Age-Related Eye Disease Study Severity Scale and Simplified Severity Scale for Age-Related Macular Degeneration
Mitchell and Foran
Arch Ophthalmol 2005;123:1598-1599.
FULL TEXT  

Responsiveness of the National Eye Institute Visual Function Questionnaire to Progression to Advanced Age-Related Macular Degeneration, Vision Loss, and Lens Opacity: AREDS Report No. 14
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1207-1214.
ABSTRACT | FULL TEXT  

A case control study of age related macular degeneration and use of statins
Smeeth et al.
Br. J. Ophthalmol. 2005;89:1171-1175.
ABSTRACT | FULL TEXT  

Autofluorescence Characteristics of Normal Foveas and Reconstruction of Foveal Autofluorescence from Limited Data Subsets
Smith et al.
IOVS 2005;46:2940-2946.
ABSTRACT | FULL TEXT